V
Visanu Thamlikitkul
Researcher at Mahidol University
Publications - 223
Citations - 7841
Visanu Thamlikitkul is an academic researcher from Mahidol University. The author has contributed to research in topics: Colistin & Acinetobacter baumannii. The author has an hindex of 37, co-authored 204 publications receiving 6446 citations. Previous affiliations of Visanu Thamlikitkul include Siriraj Hospital.
Papers
More filters
Journal ArticleDOI
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
Samira M. Garonzik,Jian Li,Jian Li,Visanu Thamlikitkul,David L. Paterson,Shmuel Shoham,Jovan Jacob,Fernanda P. Silveira,Alan Forrest,Roger L. Nation +9 more
TL;DR: Model-fitted parameter estimates were used to derive suggested loading and maintenance dosing regimens for various categories of patients, including those on hemodialysis and continuous renal replacement, and colistin may best be used as part of a highly active combination.
Journal ArticleDOI
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).
Brian T. Tsuji,Jason M. Pogue,Alexandre P. Zavascki,Mical Paul,Mical Paul,George L. Daikos,Alan Forrest,Daniele Roberto Giacobbe,Claudio Viscoli,Helen Giamarellou,Ilias Karaiskos,Donald Kaye,Johan W. Mouton,Vincent H. Tam,Visanu Thamlikitkul,Richard G. Wunderink,Jian Li,Roger L. Nation,Keith S Kaye +18 more
TL;DR: In this paper, the authors report consensus therapeutic guidelines for agent selection and dosing of colistin and polymyxin antibiotics for optimal use in adult patients, as endorsed by the American College of Clinical Pharmacy (ACCP), Infectious Diseases Society of America (IDSA), International Society of Anti-Infective Pharmacology (ISAP), Society for Critical Care Medicine (SCCM), and Society of Infectious diseases Pharmacists (SIDP).
Journal ArticleDOI
Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study
Jae-Hoon Song,Po-Ren Hsueh,Doo Ryeon Chung,Kwan Soo Ko,Cheol-In Kang,Kyong Ran Peck,Joon Sup Yeom,Shin Woo Kim,Hyun-Ha Chang,Yeon Sook Kim,Sook-In Jung,Jun Seong Son,Thomas Man-kit So,M. K. Lalitha,Yonghong Yang,Shao-Guang Huang,Hui Wang,Quan Lu,Celia C. Carlos,Jennifer Perera,Cheng-Hsun Chiu,Jien-Wei Liu,Anan Chongthaleong,Visanu Thamlikitkul,Pham Hung Van,Hyuck Lee,Thomas M. K. So,David Jien-Wei Liu,Dilip Mathai,Jennifer Perera,Tran Van Ngoc +30 more
TL;DR: It is confirmed that MRSA infections in the community have been increasing in Asian countries and data suggest that various MRSA clones have spread between the community and hospitals as well as between countries.
Journal ArticleDOI
Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study
So Hyun Kim,Jae-Hoon Song,Doo Ryeon Chung,Visanu Thamlikitkul,Yonghong Yang,Hui Wang,Min Lu,Thomas Man-kit So,Po-Ren Hsueh,Rohani Md Yasin,Celia C. Carlos,Hung Van Pham,M. K. Lalitha,Nobuyuki Shimono,Jennifer Perera,Atef M. Shibl,Jin Yang Baek,Cheol-In Kang,Kwan Soo Ko,Kyong Ran Peck +19 more
TL;DR: The most remarkable findings about the epidemiology of S. pneumoniae in Asian countries after the introduction of PCV7 were the high prevalence of macrolide resistance and MDR and distinctive increases in serotype 19A.
Journal ArticleDOI
High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.
Doo Ryeon Chung,Jae-Hoon Song,So Hyun Kim,Visanu Thamlikitkul,Shao-Guang Huang,Hui Wang,Hui Wang,Thomas Man-kit So,Rohani Md Yasin,Po-Ren Hsueh,Celia C. Carlos,Li Yang Hsu,Latre Buntaran,M. K. Lalitha,Min Ja Kim,Jun Yong Choi,Sang Il Kim,Kwan Soo Ko,Cheol-In Kang,Kyong Ran Peck +19 more
TL;DR: These isolates are highly resistant to major antimicrobial agents, which could limit the therapeutic options in the clinical practice and significantly increases the likelihood of pneumonia-related mortality.